New research focuses on biological and gender differences that shape antibiotic dosage, treatment efficacy, and outcomes in sepsis treatment.
It has also drawn attention to how biological sex and gender inequalities may contribute to suboptimal sepsis treatment and impair outcomes for women.
Despite advances in early detection and treatment, standardized antibiotic dosing often ignores patient-level variations, particularly those associated with sex-related physiology and gender disparities in care.
This study explores overlooked pharmacokinetic and pharmacodynamic differences between men and women and advocates integrating sex and gender into antibiotic administration protocols.
Improvements in sepsis diagnosis and treatment are urgently needed
Sepsis is dangerous because it is the body’s extreme and life-threatening response to infection.
As the infection spreads and triggers a widespread immune response, the body releases chemicals into the bloodstream that cause inflammation throughout the body. This can damage tissues and organs, causing decreased blood flow, low blood pressure, and organ failure.
Sepsis can progress to septic shock if not recognized and treated promptly. Septic shock can cause dangerously low blood pressure and can lead to death. Even with treatment, sepsis can lead to long-term complications such as chronic fatigue, organ dysfunction, and post-sepsis syndrome.
This condition progresses rapidly, so early detection is critical to survival. Prompt diagnosis and treatment with antibiotics and intravenous fluids are essential to reduce the risk of death and improve recovery outcomes.
There were gender disparities in several sepsis treatment areas.
Researchers found that women often face both underrepresentation in pharmacological trials for sepsis treatment and a higher risk of antibiotic overexposure.
Hormonal fluctuations, body composition, and renal clearance all influence how drugs are processed, but these variables are rarely considered in dosing algorithms.
On the other hand, men, especially younger men with increased renal clearance, may be underdosed, leading to treatment failure.
The authors write: “Standard dosing overlooks important biological differences: women are more vulnerable to side effects due to altered metabolism and reduced muscle mass, while young men often eliminate drugs too quickly to maintain therapeutic levels.”
Gender roles and bias complicate how patients are cared for
Beyond biology, gender roles and biases further complicate treatment of sepsis.
Women are less likely than men to receive aggressive or timely intervention, a difference that can be attributed to misinterpretation of symptoms, health-seeking behavior, or implicit bias within the emergency system.
These inequalities further exacerbate biological differences that already impact pharmacokinetics and pharmacodynamics. Standardized dosing often overlooks the fact that women are more susceptible to antibiotic overexposure and side effects, while younger men with increased renal clearance face underdosing and treatment failure.
These imbalances highlight the need to more precisely tailor antimicrobial therapy for sepsis treatment.
New protocols needed regarding sex and gender roles in treatment
The authors advocate the widespread use of therapeutic drug monitoring to personalize treatment and reduce both toxicity and resistance.
They also point out that less than 30% of studies currently report sex-stratified data and call on the scientific community to integrate sex and gender-aware research protocols.
Professor Jordi Rello, a co-author of the study, concluded: “Understanding sex and the differences shaped by gender is essential to advancing personalized medicine and represents a commitment to reducing equity gaps.”
Source link
